Preclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome
Nir Ayalon(Boston University), Jennifer E. Ho(Massachusetts General Hospital), Chang‐seng Liang(Neusoft (China)), Courtney Donohue(Brigham and Women's Hospital), Deirdre Mooney(Providence Sacred Heart Medical Center), Deepa M. Gopal(Boston University), Wilson S. Colucci(Boston University), Aeshita Dwivedi(Boston University), Jill Downing(Boston University), Juliana Simonetti(Boston University), Jason R. Grossman(Boston University), Noyan Gokce(Boston University), Edward J. Miller(Yale University), Alejandro J. Perez(Brigham and Women's Hospital), Caroline M. Apovian
Cited by 56
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908